← All trials
NCT04548583
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 4, 2020
- Primary completion
- Oct 31, 2023
- Completion date
- Oct 31, 2023
- First posted
- Sep 14, 2020
- Last posted
- Dec 21, 2020
- Enrollment
- 24
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- The Cleveland ClinicLead sponsor
- The Cleveland ClinicOverall official - principal investigator
- The Cleveland ClinicReponsible party - principal investigator
- Mesoblast, Inc.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.